Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for DAWES KAREN A
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-10
Sale
2021-11-12
5:12 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
4,783 $263.93 $1,262,355 91,247
(Direct)
View
2021-11-02
Sale
2021-11-04
5:41 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,400 $303.94 $729,467 91,247
(Direct)
View
2021-09-14
Sale
2021-09-15
5:46 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
274 $294.26 $80,628 93,647
(Direct)
View
2021-09-01
Sale
2021-09-02
4:29 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
3,459 $283.91 $982,058 93,921
(Direct)
View
2021-08-17
Sale
2021-08-19
4:42 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
18,956 $254.18 $4,818,219 93,921
(Direct)
View
2021-07-20
Sale
2021-07-22
8:25 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
4,585 $202.09 $926,605 112,877
(Direct)
View
2021-07-13
Sale(A)
2021-07-22
6:53 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
1,520 $202.23 $307,395 117,462
(Direct)
View
2021-07-13
Sale
2021-07-15
5:17 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
1,520 $202.23 $307,390 117,462
(Direct)
View
2021-05-11
Sale
2021-05-13
5:01 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
285 $176.85 $50,402 115,449
(Direct)
View
2021-05-04
Purchase
2021-05-06
4:29 pm
Vaccitech plc VACC DAWES KAREN A
Director
1,700 $17 $28,900 1,700
(Direct)
View
2020-06-18
Sale
2020-06-22
4:42 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
18,705 $115.2 $2,154,851 100,734
(Direct)
View
2020-05-20
Sale
2020-05-21
9:08 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
517 $139.44 $72,093 119,439
(Direct)
View
2020-05-13
Sale(A)
2020-05-21
9:06 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
1,600 $137.78 $220,448 121,717
(Direct)
View
2020-04-20
Sale(A)
2020-05-21
9:03 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
12,200 $104.57 $1,275,717 132,634
(Direct)
View
2020-05-13
Sale
2020-05-19
8:46 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
1,600 $137.78 $220,448 121,717
(Direct)
View
2020-05-08
Sale
2020-05-11
8:23 pm
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
15,834 $0.7914 $12,531 84,589
(Direct)
View
2020-04-20
Sale
2020-04-22
6:07 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
12,200 $104.57 $1,275,717 132,634
(Direct)
View
2020-02-21
Sale
2020-02-24
5:51 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
4,000 $98.7 $394,793 113,034
(Direct)
View
2019-06-17
Sale
2019-06-19
7:00 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
1,295 $77.35 $100,168 117,034
(Direct)
View
2019-06-13
Sale
2019-06-14
5:20 pm
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
12,500 $3.1835 $39,794 100,423
(Direct)
View
2018-12-03
Sale
2018-12-04
11:29 am
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
8,421 $4.8361 $40,725 42,089
(Direct)
View
2018-05-11
Sale
2018-05-15
09:53 am
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $41.8 $835,936 94,957
(Direct)
View
2017-03-21
Sale
2017-03-22
5:20 pm
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,521 $34.12 $86,017 93,243
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-11-10
Exercise
2021-11-12
5:12 pm
N/A
2026-05-11
REPLIGEN CORP RGEN DAWES KAREN A
Director
4,783 $0 91,247
(Direct)
View
2021-11-10
Exercise
2021-11-12
5:12 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
4,783 $26.12 91,247
(Direct)
View
2021-09-01
Exercise
2021-09-02
4:29 pm
N/A
2027-05-18
REPLIGEN CORP RGEN DAWES KAREN A
Director
3,459 $0 93,921
(Direct)
View
2021-09-01
Exercise
2021-09-02
4:29 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
3,459 $38.76 93,921
(Direct)
View
2021-07-13(A)
Exercise
2021-07-22
6:53 pm
N/A
2025-07-21
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,929 $0 117,462
(Direct)
View
2021-07-13(A)
Exercise
2021-07-22
6:53 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,929 $41.19 117,462
(Direct)
View
2021-07-13
Exercise
2021-07-15
5:17 pm
N/A
2025-07-21
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,929 $0 117,462
(Direct)
View
2021-07-13
Exercise
2021-07-15
5:17 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,929 $41.19 117,462
(Direct)
View
2021-05-13
Option Award
2021-05-17
9:50 pm
2022-05-13
2031-05-13
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,126 $0 117,575
(Direct)
View
2021-05-11
Exercise
2021-05-13
5:01 pm
N/A
2021-12-15
REPLIGEN CORP RGEN DAWES KAREN A
Director
15,000 $0 115,449
(Direct)
View
2021-05-11
Exercise
2021-05-13
5:01 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
15,000 $3.22 115,449
(Direct)
View
2021-04-29
Option Award
2021-05-04
8:25 pm
N/A
2031-04-29
Vaccitech plc VACC DAWES KAREN A
Director
34,328 $0 34,328
(Direct)
View
2020-05-13(A)
Option Award
2020-05-21
9:06 pm
2021-05-13
2030-05-13
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,483 $0 121,717
(Direct)
View
2020-04-20(A)
Exercise
2020-05-21
9:03 pm
N/A
2020-09-16
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $0 132,634
(Direct)
View
2020-04-20(A)
Exercise
2020-05-21
9:03 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $3.3 132,634
(Direct)
View
2020-05-13
Option Award
2020-05-19
8:46 pm
2021-05-13
2030-05-13
REPLIGEN CORP RGEN DAWES KAREN A
Director
2,483 $0 121,717
(Direct)
View
2020-04-20
Exercise
2020-04-22
6:07 pm
N/A
2020-09-16
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $0 132,634
(Direct)
View
2020-04-20
Exercise
2020-04-22
6:07 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $3.3 132,634
(Direct)
View
2019-06-17
Exercise
2019-06-19
7:00 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $4.96 117,034
(Direct)
View
2019-06-17
Exercise
2019-06-19
7:00 pm
N/A
2019-09-11
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $0 117,034
(Direct)
View
2019-05-15
Option Award
2019-05-17
4:11 pm
2020-05-15
2029-05-15
REPLIGEN CORP RGEN DAWES KAREN A
Director
4,245 $0 101,282
(Direct)
View
2019-05-07
Exercise
2019-05-09
11:28 am
2019-05-08
2019-05-08
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
31,250 $0 112,923
(Direct)
View
2019-05-07
Option Award
2019-05-09
11:28 am
N/A
N/A
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
39,584 $0 112,923
(Direct)
View
2018-12-31
Ownership
2019-02-14
4:21 pm
2018-05-15
2018-05-15
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
19,512 $0 42,089
(Direct)
View
2018-12-03
Exercise
2018-12-04
11:29 am
N/A
N/A
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
15,000 $1.49 42,089
(Direct)
View
2018-12-03
Exercise
2018-12-04
11:29 am
2009-12-09
2018-12-09
Assertio Therapeutics Inc ASRT DAWES KAREN A
Director
15,000 $0 42,089
(Direct)
View
2018-05-16
Option Award
2018-05-17
4:44 pm
2019-05-16
2028-05-16
REPLIGEN CORP RGEN DAWES KAREN A
Director
6,706 $0 101,663
(Direct)
View
2018-05-11
Exercise
2018-05-15
09:53 am
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $5.08 94,957
(Direct)
View
2018-05-11
Exercise
2018-05-15
09:53 am
N/A
2018-09-12
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $0 94,957
(Direct)
View
2018-05-08
Option Award
2018-05-10
8:08 pm
N/A
N/A
DEPOMED INC DEPO DAWES KAREN A
Director
31,250 $0 31,250
(Direct)
View
2017-08-15
Option Award
2017-08-16
6:08 pm
N/A
N/A
DEPOMED INC DEPO DAWES KAREN A
Director
19,512 $0 19,512
(Direct)
View
2017-05-18
Option Award
2017-05-22
4:56 pm
2018-05-18
2027-05-18
REPLIGEN CORP RGEN DAWES KAREN A
Director
5,173 $0 98,416
(Direct)
View
2017-03-21
Exercise
2017-03-22
5:20 pm
N/A
N/A
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $4.29 93,243
(Direct)
View
2017-03-21
Exercise
2017-03-22
5:20 pm
N/A
2017-09-14
REPLIGEN CORP RGEN DAWES KAREN A
Director
20,000 $0 93,243
(Direct)
View
(A) Indicate amendment filing.